Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Lew

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Journal of Thrombosis and Thrombolysis|April 22, 2008
Use of the TIMI frame count in the assessment of coronary artery blood flow and microvascular function over the past 15 yearsVijayalakshmi Kunadian, Caitlin Harrigan, Cafer Zorkun, et al.
Vox Sanguinis|July 17, 2015
A national common massive transfusion protocol (MTP) is a feasible and advantageous option for centralized blood services and hospitalsJ Chay, M Koh, H H Tan, et al.
Blood Advances|January 17, 2024
Venetoclax-rituximab is active in patients with BTKi-exposed CLL, but durable treatment-free remissions are uncommonThomas E Lew, Rory Bennett, Victor S Lin, et al.
Nucleic Acids Research|January 11, 2000
YPD, PombePD and WormPD: model organism volumes of the BioKnowledge library, an integrated resource for protein informationM C Costanzo, M E Crawford, J E Hirschman, et al.
Journal of Thrombosis and Thrombolysis|September 4, 2008
Transfusion associated microchimerism: a heretofore little-recognized complication following transfusionVijayalakshmi Kunadian, Cafer Zorkun, William J Gibson, et al.
Nucleic Acids Research|December 11, 1999
The yeast proteome database (YPD) and Caenorhabditis elegans proteome database (WormPD): comprehensive resources for the organization and comparison of model organism protein informationM C Costanzo, J D Hogan, M E Cusick, et al.
Nature Communications|June 7, 2022
Enhanced BRAF engagement by NRAS mutants capable of promoting melanoma initiationBrandon M Murphy, Elizabeth M Terrell, Venkat R Chirasani, et al.
Blood|September 1, 2021
Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLLPiers Blombery, Thomas E Lew, Michael A Dengler, et al.
Cancer Discovery|December 6, 2018
Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic LeukemiaPiers Blombery, Mary Ann Anderson, Jia-Nan Gong, et al.
Internal Medicine Journal|July 25, 2022
Recommendation for TP53 mutation testing in newly diagnosed mantle cell lymphoma: a statement from working groups sponsored by the Victorian Comprehensive Cancer CentreConstantine S Tam, Gareth P Gregory, Matthew Ku, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Journal of Thrombosis and Thrombolysis|April 22, 2008
Use of the TIMI frame count in the assessment of coronary artery blood flow and microvascular function over the past 15 yearsVijayalakshmi Kunadian, Caitlin Harrigan, Cafer Zorkun, et al.
Vox Sanguinis|July 17, 2015
A national common massive transfusion protocol (MTP) is a feasible and advantageous option for centralized blood services and hospitalsJ Chay, M Koh, H H Tan, et al.
Blood Advances|January 17, 2024
Venetoclax-rituximab is active in patients with BTKi-exposed CLL, but durable treatment-free remissions are uncommonThomas E Lew, Rory Bennett, Victor S Lin, et al.
Nucleic Acids Research|January 11, 2000
YPD, PombePD and WormPD: model organism volumes of the BioKnowledge library, an integrated resource for protein informationM C Costanzo, M E Crawford, J E Hirschman, et al.
Journal of Thrombosis and Thrombolysis|September 4, 2008
Transfusion associated microchimerism: a heretofore little-recognized complication following transfusionVijayalakshmi Kunadian, Cafer Zorkun, William J Gibson, et al.
Nucleic Acids Research|December 11, 1999
The yeast proteome database (YPD) and Caenorhabditis elegans proteome database (WormPD): comprehensive resources for the organization and comparison of model organism protein informationM C Costanzo, J D Hogan, M E Cusick, et al.
Nature Communications|June 7, 2022
Enhanced BRAF engagement by NRAS mutants capable of promoting melanoma initiationBrandon M Murphy, Elizabeth M Terrell, Venkat R Chirasani, et al.
Blood|September 1, 2021
Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLLPiers Blombery, Thomas E Lew, Michael A Dengler, et al.
Cancer Discovery|December 6, 2018
Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic LeukemiaPiers Blombery, Mary Ann Anderson, Jia-Nan Gong, et al.
Internal Medicine Journal|July 25, 2022
Recommendation for TP53 mutation testing in newly diagnosed mantle cell lymphoma: a statement from working groups sponsored by the Victorian Comprehensive Cancer CentreConstantine S Tam, Gareth P Gregory, Matthew Ku, et al.
Pageof 13